דטסקאן

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

IOFLUPANE

제공처:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATC 코드:

V09AB03

약제 형태:

תמיסה להזרקה

구성:

IOFLUPANE 74 MBQ/ML

관리 경로:

תוך-ורידי

처방전 유형:

מרשם נדרש

Manufactured by:

GE HEALTHCARE B.V., THE NETHERLAND

치료 그룹:

OTHER DOPAMINERGIC AGENTS

치료 영역:

IODINE IOFLUPANE (123I)

치료 징후:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

승인 날짜:

2014-11-30